Massachusetts Federal Drug Charges Attorney

Arrest, Investigation, and What Happens in the First 72 Hours

Federal drug arrests in Massachusetts fall into two categories: arrests following long-running investigations, and arrests during enforcement operations. In both cases, the government enters the courtroom with a substantial evidentiary record already assembled.

The most common pattern in Massachusetts federal drug cases begins with a DEA or FBI investigation that may have operated for months before an arrest is made. OCDETF — the Organized Crime Drug Enforcement Task Force — coordinates multi-agency investigations targeting distribution networks. These investigations typically involve Title III electronic surveillance (wiretaps), confidential informants working inside the network, controlled purchases, GPS tracking, and surveillance of known associates. By the time a warrant is executed, the government’s case file is extensive.

The first 72 hours after a federal drug arrest carry decisions with lasting consequences. Federal agents will attempt to conduct a post-arrest interview. The instinct to explain, minimize involvement, or distinguish yourself from co-defendants is understandable — and it is one of the most dangerous things a defendant can do without counsel present. Statements made to federal agents are admissible, and they will be used. Nothing said to DEA agents or FBI investigators in the hours following arrest will help the case; it can only complicate the defense.

At the initial appearance before a U.S. magistrate judge — which typically occurs within 24 hours of arrest — the court addresses detention. A federal detention hearing is not a bond hearing in the state-court sense. The government will argue for detention based on flight risk or danger to the community. The defense must present evidence of community ties, employment, family obligations, and the availability of conditions that would reasonably assure the defendant’s appearance. In drug conspiracy cases involving fentanyl distribution or OCDETF networks, the government frequently seeks detention, and the hearing requires experienced advocacy — not a first appearance by counsel who has not reviewed the complaint.

Federal Drug Charges — What the Government Must Prove

Federal drug charges in Massachusetts almost always involve conspiracy counts. Understanding what the government must prove — and where the evidentiary vulnerabilities lie — is the first step in building an effective defense.

Conspiracy to distribute under 21 U.S.C. § 846 requires the government to prove that the defendant knowingly agreed with at least one other person to distribute, or possess with intent to distribute, a controlled substance. The government does not need to prove that the defendant personally touched the drugs, personally made a sale, or knew every member of the conspiracy. It must prove knowing participation in the agreement. This creates both the prosecution’s primary lever — sweeping in individuals at every level of a distribution network — and the defense’s primary target: what did this defendant actually know, and what was the scope of the agreement he or she joined?

Distribution and possession with intent to distribute under 21 U.S.C. § 841(a)(1) requires proof that the defendant knowingly distributed a controlled substance, or possessed it with the intent to distribute. Quantity thresholds trigger mandatory minimums. For fentanyl — the dominant controlled substance in Massachusetts federal drug prosecutions — 40 grams or more triggers a 5-year mandatory minimum; 400 grams or more triggers a 10-year mandatory minimum. For defendants with prior felony drug convictions, those thresholds double. The government’s drug quantity calculation — which includes not just seized drugs but quantities attributed to the conspiracy — is frequently the single most contested factual issue in federal drug sentencing.

Aggravating factors in Massachusetts federal drug cases include use of a firearm in connection with drug trafficking, distribution near a school or playground, and leadership or supervisory roles within a distribution organization. Each carries its own sentencing enhancement under the Guidelines, and firearm possession in connection with a drug trafficking offense carries a mandatory consecutive sentence under 18 U.S.C. § 924(c) — five years mandatory, consecutive to the underlying drug sentence, for first offenses involving a firearm that was possessed in furtherance of the trafficking offense.

Bail, Detention, and Pretrial Conditions

Federal drug cases in Massachusetts — particularly those involving fentanyl distribution networks and OCDETF investigations — carry a significant risk of pretrial detention. The Bail Reform Act allows the government to seek detention on two grounds: danger to the community and risk of flight. In drug conspiracy cases, the government typically argues both.

The detention hearing is one of the most consequential events in a federal drug case. A defendant who is detained pending trial faces serious disadvantages: difficulty preparing the defense, loss of employment, separation from family, and the practical pressure to accept a plea agreement simply to resolve the case and return home. Effective detention hearing advocacy requires presenting evidence — not just argument — about ties to the community, history of court appearances, employment, family obligations, and the availability of conditions that address the government’s specific concerns.

For defendants who are released, pretrial conditions in federal drug cases typically include location monitoring or home confinement, restrictions on travel, prohibition on contact with co-defendants and alleged co-conspirators, prohibition on drug use with regular testing, and in some cases surrender of a passport. Violations of pretrial release conditions can result in immediate detention. Understanding the scope and limits of release conditions — and communicating clearly with pretrial services — requires ongoing counsel, not just representation at the detention hearing.

For families searching for counsel on behalf of a detained loved one: the detention hearing often occurs within three business days of arrest, and getting an experienced attorney into the case before that hearing is essential. If the Federal Public Defender’s office has a conflict — which occurs frequently in multi-defendant cases where the FPD already represents a co-defendant — that conflict must be identified and resolved quickly so that private counsel can be retained and prepared.

The Evidence That Decides Federal Drug Cases in Massachusetts

Federal drug prosecutions in Massachusetts are built on layered evidence. Effective defense requires understanding what the government has, how it obtained it, and where its methodology is legally vulnerable.

Wiretap evidence is central to OCDETF investigations and large-scale fentanyl distribution cases in Massachusetts. Title III authorizations require court approval and compliance with strict statutory requirements for interception, minimization, and sealing. A wiretap application that fails to establish necessity — that other investigative methods have been tried and failed, or are too dangerous — can be suppressed. The government’s minimization procedures, which require agents to cease monitoring non-pertinent calls, are frequently challenged. In cases where the wiretap evidence is the backbone of the conspiracy charge, a successful suppression motion can fundamentally alter the government’s case.

Confidential informant testimony presents credibility challenges that defense counsel must exploit at every stage. Informants in federal drug cases typically cooperate in exchange for sentence reductions, dismissal of charges, or financial payments. Their prior criminal history, the scope of their cooperation agreement, prior inconsistent statements, and the specific promises made by the government in exchange for cooperation are all areas of productive cross-examination. The government is required to disclose the existence of informants whose testimony it intends to use at trial; defense counsel must be prepared to investigate their backgrounds and use of materials.

Drug quantity attribution in conspiracy cases is frequently broader than defendants expect. The government attributes to each conspiracy member all drug quantities reasonably foreseeable within the scope of the conspiracy — not just quantities personally handled. This means that a mid-level distributor may face a guideline calculation based on the entire network’s distribution volume. Challenging the government’s drug quantity attribution through investigation, expert analysis, and sentencing advocacy is critical work that begins at indictment, not at sentencing.

Cell-site location data and digital evidence in federal drug cases includes phone records, cell tower data, GPS tracking records, and social media evidence. The government’s ability to place a defendant at specific locations at specific times, to document contact between co-conspirators, and to introduce text and call records as evidence of the conspiracy is extensive. Fourth Amendment challenges to GPS tracking warrants, stingray device use, and the government’s subpoenas for historical cell-site data are viable issues in appropriate cases.

Co-defendant cooperation is the most significant evidentiary challenge in multi-defendant federal drug cases. The government’s ability to offer substantial assistance departures — reducing sentences dramatically in exchange for testimony — creates witnesses who have powerful financial incentives to cooperate. In cases with five, ten, or twenty co-defendants, multiple cooperators may be lined up against any individual defendant. Identifying inconsistencies between cooperators, documenting the promises made in exchange for testimony, and effectively challenging cooperator credibility at trial requires thorough investigation that begins at the earliest stages of the case.

Defense Strategy in Massachusetts Federal Drug Cases

Federal drug defense is not state drug defense filed in a different courthouse. The resources, investigation, and legal complexity of federal drug prosecutions demand a defense strategy that matches the prosecution’s preparation.

Early case triage begins with obtaining and reviewing every document in the government’s possession — the complaint affidavit, detention hearing proffer, wiretap applications and authorizations, search warrant affidavits, DEA 6 reports, and any grand jury materials available through discovery. The goal is to understand the government’s theory of the case, identify the strongest evidence against the client, and assess the legal vulnerabilities in how that evidence was obtained and how it will be presented.

Suppression motion practice in federal drug cases centers on three primary areas: the Fourth Amendment validity of wiretap authorizations and the adequacy of the minimization procedures; the probable cause supporting search warrants for residences, vehicles, and electronic devices; and the voluntariness of any statements made to law enforcement. Successful suppression motions in drug cases can eliminate the government’s most powerful evidence — wiretap recordings, seized drugs, and post-arrest statements — fundamentally altering the case’s trajectory.

Drug quantity challenges are among the most consequential issues in federal drug sentencing. The guidelines calculation that drives the sentencing range is largely determined by the drug quantity the government attributes to the defendant. Challenging that attribution through cross-examination of DEA chemists, independent expert analysis of the government’s quantity methodology, and factual arguments about the scope of the specific agreement the defendant joined can produce significant reductions in the advisory guideline range — and corresponding reductions in the sentence imposed.

The safety valve under 18 U.S.C. § 3553(f) provides relief from mandatory minimum sentences for defendants who meet specific criteria: no prior criminal history beyond one criminal history point, non-violent offense, no leadership role, no gun, and truthful disclosure of all information to the government. For first-time offenders in lower-level distribution roles, safety valve eligibility can allow a sentence below the mandatory minimum — a significant benefit in cases where the minimum would otherwise be five or ten years. Determining whether a client is safety-valve eligible, and what disclosures are required to qualify, is a strategic decision that requires experienced judgment.

Cooperation and plea strategy in federal drug cases involves a detailed analysis of the government’s evidence, the guideline range, the mandatory minimum exposure, and the client’s specific circumstances and priorities. Cooperation with the government — providing information that leads to the prosecution of others — can produce a substantial assistance departure under U.S.S.G. § 5K1.1, potentially reducing a ten-year sentence to two or three years. Whether cooperation is appropriate, what its risks are, and how to negotiate the scope of cooperation in a way that maximizes benefit and minimizes exposure to additional charges requires counsel who has navigated these decisions in federal drug cases.

Trial readiness matters even in cases that ultimately resolve through plea. A defense attorney who is not prepared to try the case has no leverage in plea negotiations. The government’s calculation about whether to reduce charges, what guideline factors to agree to, and what recommendations to make at sentencing is influenced by its assessment of the defense’s ability to contest the evidence at trial.

Penalties, Mandatory Minimums, and What Sentencing Actually Looks Like

Federal drug sentencing in Massachusetts is governed by two parallel systems: the mandatory minimum statutes and the U.S. Sentencing Guidelines. Both must be understood to evaluate a case realistically.

Mandatory minimum sentences under 21 U.S.C. § 841(b) apply when the government proves the defendant was responsible for specified drug quantities. For fentanyl, which dominates Massachusetts federal drug prosecutions:

• 40 grams or more: 5-year mandatory minimum (up to 40 years maximum)
• 400 grams or more: 10-year mandatory minimum (up to life maximum)
• Prior felony drug conviction doubles each threshold
• Two prior felony drug convictions triggers mandatory life for the 400-gram threshold

The Sentencing Guidelines produce an advisory range through the calculation of a base offense level (driven primarily by drug quantity), criminal history category, and applicable adjustments for role in the offense, obstruction of justice, acceptance of responsibility, and other factors. In a typical multi-defendant fentanyl distribution case in Massachusetts, the guideline range for a mid-level distributor with no prior convictions might run from 70 to 87 months — above the 5-year mandatory minimum — meaning the mandatory minimum does not control the outcome, but the Guideline range does.

Collateral consequences of federal drug convictions extend beyond the sentence. A federal felony drug conviction bars eligibility for federal student loans, federal employment, public housing, and — for non-citizens — triggers removal proceedings and bars to reentry. For defendants with professional licenses, a federal drug conviction typically initiates licensing proceedings. For parents with custody arrangements, a federal sentence produces family disruption that can outlast the prison term.

Why Experience in Massachusetts Federal Drug Defense Matters

Federal drug prosecutions in the District of Massachusetts are built by experienced AUSA teams working with DEA, FBI, and OCDETF resources. Effective defense requires counsel who has worked within federal criminal procedure, who understands how to challenge electronic surveillance evidence and cooperator credibility, and who knows the practical culture of the Boston, Worcester, and Springfield federal courthouses.

Attorney Stefanie A. Murphy brings demonstrated serious felony trial experience to every federal matter the firm handles. The Providence Journal has covered Murphy’s work across murder acquittals, wrongful conviction DNA litigation, and high-profile jury trials — cases where the stakes were irreversible and the quality of advocacy directly determined the outcome. In a reported murder acquittal where co-defendants were serving life sentences, Murphy’s defense of her client produced a not-guilty verdict despite the prosecution of the Attorney General’s Office. Rhode Island Lawyers Weekly has identified both Murphy and Matthew T. Marin as attorneys who have shaped constitutional litigation on search-and-seizure law — the same Fourth Amendment analysis that governs wiretap and warrant challenges in federal drug cases.

Murphy’s authorship of the MCLE New England treatise A Practical Guide to Trying DUI Cases in Rhode Island (2nd Edition 2024) and her work lecturing to the Rhode Island Municipal Police Training Academy reflect a command of evidentiary and trial practice that translates directly to the suppression hearing and trial preparation demands of federal drug cases.

Marin & Murphy’s federal practice spans Rhode Island, Connecticut, and Massachusetts. Attorney Stefanie A. Murphy is admitted to the U.S. District Court for the District of Massachusetts (D. Mass. Federal Bar #663646). Matthew T. Marin is admitted in Massachusetts state courts (BBO #672462). Clients facing federal charges in Boston, Worcester, or Springfield receive representation from attorneys who understand not only the specific courthouse and its culture, but the First Circuit precedent that governs suppression issues, sentencing appeals, and constitutional challenges across the region.

That same trial depth carries into post-conviction litigation when a conviction must be challenged under 28 U.S.C. § 2255.